Greg Finak is a technology and science leader with 13 years of experience translating high-dimensional immunology and single-cell assays into robust statistical methods, software, and production analytics. As Interim CEO, CTO and co-founder of Ozette he combines hands-on engineering leadership with a deep research pedigree from senior roles at Fred Hutch where he led vaccine immunology statistics and maintained core Bioconductor flow cytometry infrastructure. Trained as a PhD biochemist/bioinformatician at McGill, he builds reproducible pipelines, R packages, and Bayesian models that bridge rigorous research and deployable products. Greg’s career blends entrepreneurship, grant-funded academic stewardship, and consulting for pharma on biomarker discovery, reflecting a rare mix of scientific rigor and startup pragmatism. Based in Seattle, he is serious about reproducibility and pushing technological boundaries while keeping work directly tied to impactful biomedical outcomes.
13 years of coding experience
17 years of employment as a software developer
PhD Biochemistry Bioinformatics, PhD Biochemistry Bioinformatics at McGill University
Contributions:4 releases, 17 pushes, 1 branch in 5 years 7 months
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Greg Finak - Interim CEO, CTO And Co-founder at Ozette